Relfol 100mg/1.5mg Tablet
79,00 ₹
Analogs of Relfol 100mg/1.5mg Tablet
Find cheaper analogs and generic equivalents for Relfol 100mg/1.5mg Tablet.
Active Ingredient: ferrous ascorbate, folic acid
Product Overview
About Relfol 100mg/1.5mg Tablet
Relfol 100mg/1.5mg Tablet is a pharmaceutical product formulated to address nutritional deficiencies. This medication combines two essential components that work in tandem to support healthy blood production and overall physiological function. It is typically prescribed by healthcare professionals to manage conditions related to low iron levels and folate deficiency. Each tablet is manufactured to ensure precise delivery of its active ingredients, providing a reliable option for patients requiring supplementation as part of their therapeutic regimen. Patients should always follow the specific dosage instructions provided by their physician to ensure safety and efficacy during the course of treatment.
Key Benefits & Uses
- Supports the management of iron deficiency anemia.
- Provides essential folic acid to assist in healthy cell division.
- Helps restore adequate iron stores within the body.
- Assists in maintaining normal hemoglobin levels for improved oxygen transport.
Active Ingredient & Action
The active ingredients in Relfol 100mg/1.5mg Tablet are Ferrous Ascorbate and Folic Acid. Ferrous Ascorbate provides a bioavailable form of iron, which is a critical component of hemoglobin. Folic Acid, a member of the B-vitamin family, is necessary for the synthesis of DNA and the maturation of red blood cells.
Important Notes
This medicine should be stored in a cool, dry place away from direct sunlight. Keep the product out of the reach of children at all times. Consult your doctor before starting this medication if you have any pre-existing medical conditions or are currently taking other supplements.
Find in Pharmacies
Compare local prices and distance for Relfol 100mg/1.5mg Tablet.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.